Innovation Pharmaceuticals Inc (IPIX)

[LilyGDog]

Awesome post George, next week might be our week. Thank you for posting that information. Nasdaq here we come...

Go Leo & IPIX!

Why Prurisol is worth at least $10 Billion!!!

At 300 mg per day and 400 mg per day Prurisol as an inexpensive and convenient oral drug will capture more of the market share now held by more expensive biologic treatments that currently are estimated to be over $8 billion per year.

Prurisol is worth at least twice what Otezla is worth!!!

Look up net present value which considers the years of revenues of say $6 billion each and every year for over a decade.

Also, Prurisol will be effective for other inflammatory diseases and conditions including arthritis including psoriatic arthritis, rheumatoid arthritis, osteoarthritis, multiple myeloma, asthma, etc.

Comments from the principle investigators from the previously completed Prurisol Phase 2a trial:

Quote:
Investigator Comments
Cellceutix would also like to share some observations and comments from Principle Investigators (PIs) overseeing different participating clinical sites in the trial. Numerous PIs noted patients expressed a desire to have access to Prurisol following the study's conclusion. Moreover, the Company learned that some patients were previously unsuccessfully treated with other therapies, including biologics and apremilast (Otezla®).
Included below is a sampling of responses that were authorized to be published:
"Well designed study, patients were pleased, minimal to no side effects."
"Good tolerability was shown with very few AEs reported. Good compliance and good patient satisfaction."
"Overall impression of the study is very positive, as well as the patients' satisfaction."
When asked, "Why would you choose Prurisol (should it be approved) over another oral compound for psoriasis?" and "Why would you choose Prurisol over an injectable biologic?" responses included:
"Because [Prurisol] does not cause any severe side effects. Patients dislike needles and injections because they cause pain and discomfort."
"Patients overall prefer oral medications over injectable medication. Our experience with injectable studies for other indications has been that many subjects do not like taking them and those studies tend to be difficult compared to oral medications to recruit subjects."
"Because of [Prurisol's] low side effect profile."
"Patients prefer oral treatments."